Analyst Price Targets — DLB
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 19, 2025 9:26 am | Steve Frankel | Rosenblatt Securities | $85.00 | $64.96 | StreetInsider | Dolby Laboratories (DLB) PT Lowered to $85 at Rosenblatt |
| September 4, 2025 8:24 pm | Vikram Kesavabhotla | Robert W. Baird | $74.00 | $72.79 | TheFly | Dolby initiated with a Neutral at Baird |
| May 15, 2025 1:43 pm | Ivan Feinseth | Tigress Financial | $112.00 | $77.24 | TheFly | Dolby reinstated with a Buy at Tigress Financial |
| February 3, 2023 8:26 am | — | Rosenblatt Securities | $90.00 | $82.67 | Benzinga | Rosenblatt Maintains Buy on Dolby Laboratories, Raises Price Target to $90 |
Latest News for DLB
Dolby Laboratories (NYSE: DLB - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the five brokerages that are covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month price objective among
SAN FRANCISCO, April 8, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the second quarter (Q2) fiscal year 2026 after the close of regular trading on Thursday, April 30, 2026. Members of Dolby management will lead a conference call open to all interested parties to discuss Q2 fiscal year 2026 financial results for Dolby…
Dolby Laboratories (DLB) offers a compelling risk-reward profile with high margins, robust free cash flow, and a reasonable valuation. DLB's intrinsic value is estimated near $80 per share, implying 36% upside from current levels and supporting a double-digit annual return outlook. Growth is driven by expanding automotive, mobile, and streaming partnerships, with 93% of sales from licensing and strong IP protection.
Dolby Laboratories (NYSE: DLB - Get Free Report) has been assigned an average rating of "Moderate Buy" from the five brokerages that are currently covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12-month price target among
Dolby Laboratories (NYSE: DLB - Get Free Report) shares reached a new 52-week low during mid-day trading on Thursday. The company traded as low as $58.13 and last traded at $58.6210, with a volume of 697088 shares. The stock had previously closed at $58.87. Wall Street Analyst Weigh In A number of analysts have recently
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for DLB.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.